Health Care & Life Sciences » Biotechnology | Palatin Technologies Inc.

Palatin Technologies Inc. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
10.40
-
12,951.70
-
44,723.80
67,134.80
Cost of Goods Sold (COGS) incl. D&A
-
111.90
-
43.10
-
-
Gross Income
-
111.90
-
43.10
-
-
SG&A Expense
15,483.70
15,675.70
30,120.30
49,207.10
55,260.30
41,151.60
EBIT
15,585.20
15,787.70
17,286.20
-
10,569.50
25,926.60
Unusual Expense
7,069.20
-
-
-
-
-
Non Operating Income/Expense
4.60
-
284.70
-
-
-
Interest Expense
8.40
6.20
661.70
2,513.00
2,288.30
1,452
Pretax Income
22,615.40
15,774.90
18,197.10
51,712.90
12,831.50
24,785.20
Income Tax
1,753.20
1,846.60
531.50
-
500.00
82.50
Consolidated Net Income
20,862.20
13,928.30
17,665.60
51,712.90
13,331.50
24,702.70
Net Income
20,862.20
13,928.30
17,665.60
51,712.90
13,331.50
24,702.70
Net Income After Extraordinaries
20,862.20
13,928.30
17,665.60
51,712.90
13,331.50
24,702.70
Net Income Available to Common
20,862.20
13,928.30
17,665.60
51,712.90
13,331.50
24,702.70
EPS (Basic)
0.21
0.13
0.15
0.33
0.07
0.12
Basic Shares Outstanding
97,618.70
106,679.50
121,014.50
156,553.50
184,087.70
198,101.10
EPS (Diluted)
0.21
0.13
0.15
0.33
0.07
0.12
Diluted Shares Outstanding
97,618.70
106,679.50
121,014.50
156,553.50
184,087.70
207,007.60
EBITDA
15,473.30
15,675.70
17,168.60
49,207.10
10,536.40
25,983.10
Non-Operating Interest Income
42.70
18.90
35.40
50.20
26.30
310.70

About Palatin Technologies

View Profile
Address
Cedar Brook Corporate Center
Cranbury New Jersey 08512
United States
Employees -
Website http://www.palatin.com
Updated 07/08/2019
Palatin Technologies, Inc. is a biopharmaceutical company which develops targeted, receptor-specific peptide therapeutics for the treatment of diseases. It specializes in molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. It offers product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder, which is a type of female sexual dysfunction, defined as low desire with associated distress.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.